NASDAQ:ANIP ANI Pharmaceuticals Q3 2026 Earnings Date & Estimates $72.60 -0.01 (-0.01%) Closing price 04:00 PM EasternExtended Trading$73.86 +1.26 (+1.73%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ANI Pharmaceuticals is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from ANI Pharmaceuticals in Q3 2026ANI Pharmaceuticals is expected to post earnings of $2.18 per share on revenue of $280.26 million. In the same quarter a year earlier ANI Pharmaceuticals reported $2.04 per share on revenue of $227.81 million. ANI Pharmaceuticals last reported on August 7, 2026, posting $2.21 per share and beating the $2.04 consensus estimate. ANI Pharmaceuticals has beaten the consensus EPS estimate in 8 of its last 8 quarters.Consensus EstimatesConsensus EPS$2.18Expected Revenue$280.26 millionPrior-Year EPS$2.04Prior-Year Revenue$227.81 millionExpected EPS Growth+6.9%Expected Revenue Growth+23.0%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$2.21 (Beat by +$0.17)Last Quarter Revenue$266.04 millionEPS Beat Rate8 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ3 2025 Earnings Report ANI Pharmaceuticals Q3 2026 Earnings FAQ When does ANI Pharmaceuticals report Q3 2026 earnings? ANI Pharmaceuticals (NASDAQ:ANIP) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is ANI Pharmaceuticals' Q3 2026 earnings call? ANI Pharmaceuticals' Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for ANI Pharmaceuticals? Analysts expect ANI Pharmaceuticals to post earnings of $2.18 per share for Q3 2026. How much revenue is ANI Pharmaceuticals expected to report? The consensus revenue estimate for ANI Pharmaceuticals is $280.26 million for Q3 2026. ANI Pharmaceuticals Earnings HeadlinesJ.P. Morgan Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP)October 24 at 5:32 PM | theglobeandmail.comANI Pharmaceuticals (NASDAQ:ANIP) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?October 24 at 3:23 AM | americanbankingnews.comExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December. The agenda at the upcoming G20 Summit in Miami has shifted, and new research points to a major monetary announcement from President Trump. A new documentary breaks down what this shift could mean for savings, investments, and the assets tied to it.October 26 at 1:00 AM | Porter & Company (Ad)ANI Pharmaceuticals' Eye-Care Franchise Faces New Competition, Oppenheimer SaysOctober 23 at 8:12 PM | finance.yahoo.comANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ETOctober 23 at 6:55 AM | globenewswire.comANI Pharmaceuticals Launches Generic CymbaltaOctober 19, 2026 | finance.yahoo.comSee More ANI Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ANI Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ANI Pharmaceuticals and other key companies, straight to your email. Email Address About ANI PharmaceuticalsANI Pharmaceuticals (NASDAQ:ANIP) is a specialty pharmaceutical company that develops, manufactures and markets branded and generic prescription medicines. The company focuses on products with limited competition, complex formulations and specialized manufacturing requirements, serving therapeutic areas that include endocrinology, immunology, ophthalmology, dermatology and central nervous system disorders. ANI’s portfolio includes branded products and generic medicines, as well as treatments for rare diseases. Its products include Cortrophin-Zinc, a repository corticotropin injection used for certain inflammatory and autoimmune conditions, along with a range of other prescription therapies. The company also maintains a pipeline of internally developed, acquired and partnered products. ANI Pharmaceuticals primarily serves the United States through its commercial, manufacturing and distribution operations. The company’s corporate headquarters are in Princeton, New Jersey, and it operates pharmaceutical manufacturing and development facilities in the United States. Nikhil Lalwani serves as president and chief executive officer.View ANI Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure GiantsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big CatalystsComfort Systems Earnings: AI Slowdown or More Growth Ahead?MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline Upcoming Earnings Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Baker Hughes (10/27/2026)ONEOK (10/27/2026)Robinhood Markets (10/27/2026)HSBC (10/27/2026)S&P Global (10/27/2026)Visa (10/27/2026)HCA Healthcare (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
